AZN

AstraZeneca

Market Cap 710,672.9M
Today
Day High
N/A
562
Day Low
N/A
Day Open
562.00
Prev Close
562.00
VWAP
N/A
Volume
71K
Turnover
36.341M
Top Broker
NRD
VWAP
560.6
Avg Volume
435K
Avg Turnover
243.884M
Top Brokers
SWB/AVA
VWAP
559.3
Avg Volume
461K
Avg Turnover
258.064M
Top Brokers
NRD/SWB
VWAP
562.4
Avg Volume
425K
Avg Turnover
239.002M
Top Brokers
NRD/CAR
52 week summary
Price Range
461.3
Last
622.0
Beta
N/A
Market Cap
710,672.9M
Total Return
16.8%
Trailing P/E
N/A
Div Yield
N/A%
Shares Outstanding
1,264.5M
Next Earnings Date
2 Feb
Stock Exchange
NASDAQ Stockholm
5 day chart Go to advanced chart

Identify and measure trend strength in stocks with our Momentum tool to identify potential entry and exit signals. The tool provides a set of the most simple but powerful indicators that identify whether a stock is under sell or buy pressure.


Relative Price Strength
Change 3 Months 13.2%
Change 12 Months 2.5%
Volume Trend
Average Volume 10 vs 60 Days 6.1%
Price VS
52 Week High -9.6%
50 Day Moving Average 0.2%
200 Day moving Average 2.8%

Add article markers

Compare AstraZeneca to

Prev Close 0 Change 0
High 0 Avg Daily Volume 0
Low 0 Avg Daily Turnover 0
  • Management
  • Pascal Soriot, CEO
  • Executive board
  • Leif Johansson, Chairman of the board
Source: Millistream
Major Owners Equity Votes
BlackRock, Inc. 8.0%
8.0%
Investor AB 4.1%
4.1%
Source: Millistream
  •  
  • Profitability
  • ROE
  • ROCE
  • ROIC
  • EBITDA margin
  • EBIT margin
  • Net margin
  • Per share data (SEK)
  • EPS
  • EPS adj
  • Dividend
  • Net debt
  • Total shares
  • Valuation
  • EV (SEKm)
  • P/E
  • P/E diluted
  • P/Sales
  • EV/Sales
  • EV/EBITDA
  • EV/EBIT
  • P/BV
  • Capital structure
  • Equity ratio
  • Debt/equity ratio
  • Net debt(SEKm)
  • Capital employed(SEKm)
  • Capital turnover rate
  • (SEKm)
  • Net sales
  • Total operating costs
  • EBITDA
  • Depreciation
  • Amortization
  • Impairment charges
  • EBIT
  • Share in profits
  • Net financial items
  • Exchange rate dif.
  • Pre-tax profit
  • Tax
  • Net earnings
  • (SEKm)
  • Assets
  • Current assets
  • Cash in banks
  • Receivables
  • Inventories
  • Other current assets
  • Current assets
  • Fixed assets
  • Tangible assets
  • Associated comp.
  • Investments
  • Goodwill
  • Cap. exp. for dev.
  • O intangible rights
  • O non-current assets
  • Total fixed assets
  • Deferred tax assets
  • Total (assets)
  • Liabilities
  • Current liabilities
  • Short-term debt
  • Accounts payable
  • O current liabilities
  • Current liabilities
  • Long-term debt
  • O long-term liabilities
  • Convertibles
  • Total Liabilities
  • Deferred tax liab
  • Provisions
  • Shareholders' equity
  • Minority interest (BS)
  • Minority & equity
  • Total liab & SE
  • (SEKm)
  • Net sales
  • Total operating costs
  • Depreciations total
  • EBIT
  • Taxes on EBIT
  • NOPLAT
  • Depreciation
  • Gross cash flow
  • Change in WC
  • Gross CAPEX
  • Free cash flow

Estimated Values is behind membership

To access members-only content, you must login or register an account.

Our membership is about gaining access to unique research and knowledge through our analysts and a network of peers. Be the first to get information about news and research in the Nordic life science and technology sectors and use our tools and education to reach your personal and professional goals in investing.

Source: Redeye
Source: Redeye

Presentations, research interviews and videos from our events listed here.


Source: Redeye